十大网赌网站注册app网·主頁欢迎您

    <output id="zikax"><ruby id="zikax"><xmp id="zikax"></xmp></ruby></output>

  1. <p id="zikax"><del id="zikax"></del></p>
    <output id="zikax"></output>
    1. <acronym id="zikax"><label id="zikax"></label></acronym>
    2. Archive Videos

       

      Dermatitis Educational Programming


      Advances in Treatment of Herpes Zoster Infection

      Program no. MA-0616M, 120 minutes
      Presenters: Karl Buetner, MD; Richard Whitley, MD; Robert Dworkin, MD; John F. Flahery, PharmD; John Wolf, MD
      The Pain Benefit for Anti-Herpetic Therapy in the Elderly; Therapeutic Advances in H. Zoster; Pharmacokinetics and Differentiation of Anti-Viral Therapy; Herpes Zoster: Pain Analysis.

      $289.00 USD

      Management of Herpes Zoster

      Program no. MA-1012M, 120 minutes
      Presenters: Myron J. Levin, MD; Larry Gelb, MD; Michael Oxman, MD; Allyn Bandell, PharmD; Peter Watson, MD; Wayne Gray, PhD
      A panel of leading dermatologists, infectious disease physicians and managed care professionals will apply disease management principles to the diagnosis and treatment of Herpes Zoster.

      $289.00 USD

      Advances in Treatment of Herpes Zoster

      Program no. MB-0302M, 120 minutes
      Presenters: Karl Buetner, MD; Richard Whitley, MD; Robert Dworkin, MD; John F. Flahery, PharmD; John Wolf, MD
      The Pain Benefit for Anti-Herpetic Therapy in the Elderly; Therapeutic Advances in H. Zoster; Pharmacokinetics and Differentiation of Anti-Viral Therapy; Herpes Zoster: Pain Analysis.

      $289.00 USD

      Advances in the Treatment of Genital Herpes

      Program no. MC-0516M, 90 minutes
      Presenters: Antonio Buzaid, MD; Merick Ross, MD
      Adjuvant Therapy: Interferon and New Advances in Patients with Advanced Diseases; Diagnosis and Prognosis of Primary Melanoma.

      $249.00 USD

      Recent Advances in Treatment of Cutaneous Fungal Infections (Onychomycosis)

      Program no. MD-0408M, 90 minutes
      Presenters: Norman Guzick, MD; Phoebe Rich, MD - John Wolf, MD; H. Irving Katz, MD
      Psychosocial Ramifications and Epidemiology; Diagnosis and Differential; Current Treatment Strategies for Onychomycosis; Safety Concerns Regarding Drug Interaction Potential and Liver Metabolism.

      $249.00 USD

      Pressure Ulcers: Prevention & Treatment

      Program no. ME-0526N, 60 minutes
      Presenters: Mary Y. Sieggreen, RN, CS, CNP, CVN, MSN; Maria Palleschi, MSN, RN, CCRN; JoAnn Maklebust, MSN, RN, CS, NP.
      Describes the most common pressure ulcer risk factors and the wound healing process; Identify methods for pressure ulcer prevention and treatment.

      $209.00 USD

      Antifungal Therapy Beyond the Year 2000

      Program no. ME-0618M, 150 minutes
      Presenters: Boni E. Elewski, MD; Hideoki Ogawa; David T. Roberts; Bardur Sigurgeirsson; Christa de Cuyper; D. O'Sullivan; Irving Katz, MD; E.G.V. Evans, PhD, FRCPath; R.J. Hay, DM, FRCPath
      Understand the newest treatment regimens in onychomycosis therapy. Discuss the safety profile of antimycotics including side effects and drug interactions. Recognize the challenges in the management of onychomycosis. Discuss the long-term outcome of onychomycosis treatment.

      $309.00 USD
      MEDIVISION ? does not warrant the accuracy of this information, and it is intended as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of healthcare professionals. If you have questions about health care, please consult a physician or other health care professionals.
      十大网赌网站注册app网